Internal Medicine, Sakura Hospital, School of Medicine, Toho University, Chiba, Japan.
J Atheroscler Thromb. 2011;18(1):49-55. doi: 10.5551/jat.3582. Epub 2010 Nov 6.
The cardio-ankle vascular stiffness index (CAVI) is a new parameter that reflects the stiffness of the aorta, femoral artery and tibial artery as a whole. One of its conspicuous features is that CAVI is independent of blood pressure at measuring time, theoretically. But, it has not been experimentally proved yet. For confirmation, pharmacological studies were performed comparing with brachial-ankle pulse wave velocity (baPWV).
Used drugs were a β1-adrenoceptor blocker, metoprorol and an α1- adrenoceptor blocker doxazosin. Both were administered to 12 healthy volunteer men. CAVI and baPWV were measured every one hour for 6 hours using VaSera.
When metoprolol (80 mg) was administered to 12 healthy volunteer men, systolic blood pressure decreased from 131.4 ± 4.5 to 118.3 ± 4.1 mmHg (mean ± SE) (p < 0.05) at the 3rd hour, and diastolic blood pressure decreased from 85.3 ± 4.0 to 75.3 ± 3.0 mm Hg (p < 0.05). baP-WV decreased from 13.93 ± 0.46 to 12.46 ± 0.49 m/sec (p < 0.05), significantly, but CAVI did not change (8.16 ± 0.29 to 8.24 ± 0.27) (p = 0.449). ΔbaPWV at each time was significantly correlated with both Δsystolic and Δdiastolic blood pressures, but ΔCAVI was not correlated with either Δblood pressure. When doxazosin (4 mg) was administered to the same men, systolic blood pressure decreased from 130.2 ± 4.6 to 117.2 ± 4.8 mmHg (p < 0.05) at the 3rd hour. Diastolic blood pressure also decreased from 85.1 ± 4.1 to 74.2 ± 3.9 mmHg (p < 0.05). baPWV decreased from 13.98 ± 0.68 to 12.25 ± 0.53 m/sec (p < 0.05), significantly. CAVI also decreased from 8.15 ± 0.28 to 7.18 ± 0.37 (p < 0.05), significantly.
These results suggested that CAVI was not affected by blood pressure at the measuring time directly, but affected by the changes of contractility of smooth muscle cells.
心血管踝动脉僵硬指数(CAVI)是一种新的参数,反映了主动脉、股动脉和胫动脉的整体僵硬程度。其显著特点之一是,理论上,CAVI 不受测量时血压的影响。但尚未经过实验验证。为了确认这一点,我们进行了药理学研究,将其与臂踝脉搏波速度(baPWV)进行了比较。
使用的药物为β1-肾上腺素能受体阻滞剂美托洛尔和α1-肾上腺素能受体阻滞剂多沙唑嗪。这两种药物均给予 12 名健康志愿者男性。使用 VaSera 每小时测量一次 CAVI 和 baPWV,共测量 6 小时。
当 12 名健康志愿者男性给予美托洛尔(80mg)时,收缩压从 131.4±4.5mmHg 降至 118.3±4.1mmHg(均值±SE)(p<0.05),第 3 小时,舒张压从 85.3±4.0mmHg 降至 75.3±3.0mmHg(p<0.05)。baPWV 从 13.93±0.46m/sec 降至 12.46±0.49m/sec(p<0.05),显著降低,但 CAVI 没有变化(8.16±0.29to8.24±0.27)(p=0.449)。每个时间点的 ΔbaPWV 与 Δ收缩压和 Δ舒张压均显著相关,但 ΔCAVI 与任何血压均不相关。当给予同一男性多沙唑嗪(4mg)时,收缩压从 130.2±4.6mmHg 降至 117.2±4.8mmHg(p<0.05),第 3 小时。舒张压也从 85.1±4.1mmHg 降至 74.2±3.9mmHg(p<0.05)。baPWV 从 13.98±0.68m/sec 降至 12.25±0.53m/sec(p<0.05),显著降低。CAVI 也从 8.15±0.28降至 7.18±0.37(p<0.05),显著降低。
这些结果表明,CAVI 不受测量时血压的直接影响,但受平滑肌细胞收缩力变化的影响。